• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

在繁忙的基层医疗设施中使用赛沛Xpert® HPV进行自我采样和HPV检测的可行性与可接受性。

The feasibility and acceptability of self-sampling and HPV testing using Cepheid Xpert® HPV in a busy primary care facility.

作者信息

Woo Y L

机构信息

Faculty of Medicine, University of Malaysia on behalf of ROSE team.

出版信息

J Virus Erad. 2019 Mar 4;5(Suppl 1):10-11. doi: 10.1016/S2055-6640(20)30063-7.

DOI:10.1016/S2055-6640(20)30063-7
PMID:30997147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6428151/
Abstract

Malaysia's approach to reducing the burden of HPV-related disease has centred on adolescent vaccination and cervical screening with Pap smears. While the vaccination programme has been broadly successful, Pap smear screening has been less successful. In an effort to improve screening uptake, the ROSE 1.0 pilot aimed to create more efficient screening, with improved quality and lower total cost.

摘要

马来西亚减轻人乳头瘤病毒相关疾病负担的方法主要集中在青少年疫苗接种和巴氏涂片宫颈筛查上。虽然疫苗接种计划总体上取得了成功，但巴氏涂片筛查的成效较小。为了提高筛查的接受率，ROSE 1.0试点项目旨在实现更高效的筛查，提高质量并降低总成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/6428151/029b4bda4ae8/JVE-5-10-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/6428151/029b4bda4ae8/JVE-5-10-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7246/6428151/029b4bda4ae8/JVE-5-10-g001.jpg

相似文献

1
The feasibility and acceptability of self-sampling and HPV testing using Cepheid Xpert® HPV in a busy primary care facility.在繁忙的基层医疗设施中使用赛沛Xpert® HPV进行自我采样和HPV检测的可行性与可接受性。
J Virus Erad. 2019 Mar 4;5(Suppl 1):10-11. doi: 10.1016/S2055-6640(20)30063-7.
2
Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.巴氏涂片筛查、人乳头瘤病毒 DNA 检测与疫苗接种的成本效益分析。
J Eval Clin Pract. 2011 Dec;17(6):1050-8. doi: 10.1111/j.1365-2753.2010.01453.x. Epub 2011 Jun 16.
3
Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid.在SurePath保存液中，比较Cepheid Xpert人乳头瘤病毒检测法与HC2高危型人乳头瘤病毒DNA检测法对宫颈涂片样本中高危型人乳头瘤病毒感染的检测情况。
J Med Microbiol. 2018 May;67(5):676-680. doi: 10.1099/jmm.0.000723.
4
Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening.人乳头瘤病毒DNA自我采样对宫颈癌筛查接受度的影响评估
Cancer Nurs. 2016 Jan-Feb;39(1):E1-E11. doi: 10.1097/NCC.0000000000000241.
5
Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.人乳头瘤病毒疫苗接种后时代宫颈癌筛查的前景策略。
Sex Health. 2010 Sep;7(3):376-82. doi: 10.1071/SH10022.
6
HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.HPV 自我采样或巴氏涂片检查：法国社会经济地位较低的宫颈癌筛查未参与者中一项随机研究。
Int J Cancer. 2013 Dec 1;133(11):2681-7. doi: 10.1002/ijc.28283. Epub 2013 Jul 23.
7
Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.农村筛查不足女性人乳头瘤病毒检测自我采样的随机干预：筛查接受情况与可接受性
J Womens Health (Larchmt). 2016 May;25(5):489-97. doi: 10.1089/jwh.2015.5348. Epub 2015 Nov 24.
8
Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution.巴氏涂片检查与人乳头瘤病毒（HPV）检测作为宫颈癌筛查工具的比较：我们能否仅依靠HPV检测作为一种筛查方法？来自单一机构的11年回顾性经验。
J Pathol Transl Med. 2020 Jan;54(1):112-118. doi: 10.4132/jptm.2019.11.29. Epub 2020 Jan 15.
9
The acceptability of self-collected samples for HPV testing vs. the pap test as alternatives in cervical cancer screening.在宫颈癌筛查中，与巴氏试验相比，自我采集样本用于人乳头瘤病毒（HPV）检测的可接受性作为替代方法。
J Womens Health Gend Based Med. 2002 Apr;11(3):265-75. doi: 10.1089/152460902753668466.
10
Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.在马来西亚多民族女性中，影响自我采集宫颈阴道样本进行人乳头瘤病毒（HPV）基因分型以替代巴氏试验的可接受性的态度和因素。
BMJ Open. 2016 Aug 4;6(8):e011022. doi: 10.1136/bmjopen-2015-011022.

引用本文的文献

1
Evaluation of () as a Sample Adequacy Control in HPV Molecular Diagnostics.评估（）作为人乳头瘤病毒分子诊断中样本充足性控制的情况。 （括号内内容缺失，无法准确完整翻译）
Diagnostics (Basel). 2024 Sep 30;14(19):2194. doi: 10.3390/diagnostics14192194.
2
The levels of women's awareness, experience, acceptability and preference for Vaginal Human Papillomavirus (HPV) self-sampling in three provinces of China: a cross-sectional study.中国三个省份女性对阴道人乳头瘤病毒（HPV）自我采样的知晓率、经验、可接受性和偏好程度的横断面研究。
BMC Womens Health. 2024 Jun 15;24(1):343. doi: 10.1186/s12905-024-03186-w.
3
The impact of alternate HPV vaccination and cervical screening strategies in Japan: a cost-effectiveness analysis.
日本交替人乳头瘤病毒（HPV）疫苗接种与宫颈癌筛查策略的影响：一项成本效益分析
Lancet Reg Health West Pac. 2024 Feb 19;44:101018. doi: 10.1016/j.lanwpc.2024.101018. eCollection 2024 Mar.
4
Prevalence and sociodemographic predictors of high-risk vaginal human papillomavirus infection: findings from a public cervical cancer screening registry.高危型阴道人乳头瘤病毒感染的流行情况及社会人口学预测因素：来自公共宫颈癌筛查登记处的研究结果。
BMC Public Health. 2023 Nov 14;23(1):2243. doi: 10.1186/s12889-023-17132-2.
5
Exploring factors associated with preferences for human papillomavirus (HPV) self-sampling among racially- and ethnically-diverse women in Minnesota: A cross-sectional study.探索明尼苏达州不同种族和族裔女性对人乳头瘤病毒（HPV）自我采样偏好的相关因素：一项横断面研究。
Prev Med Rep. 2023 May 13;34:102243. doi: 10.1016/j.pmedr.2023.102243. eCollection 2023 Aug.
6
Self-Collection Cervical Screening in the Asia-Pacific Region: A Scoping Review of Implementation Evidence.亚太地区的自我采集宫颈筛查：实施证据的范围综述。
JCO Glob Oncol. 2023 Jan;9:e2200297. doi: 10.1200/GO.22.00297.
7
Health care personnel's perspectives on human papillomavirus (HPV) self-sampling for cervical cancer screening: a pre-implementation, qualitative study.医护人员对用于宫颈癌筛查的人乳头瘤病毒（HPV）自我采样的看法：一项实施前的定性研究
Implement Sci Commun. 2022 Dec 13;3(1):130. doi: 10.1186/s43058-022-00382-3.
8
The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support.马来西亚消除宫颈癌的道路：评估自我采集和数字登记支持的人乳头瘤病毒筛查的影响和成本效益。
Int J Cancer. 2021 Dec 15;149(12):1997-2009. doi: 10.1002/ijc.33759. Epub 2021 Aug 25.
9
Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South Asia.东亚、东南亚和南亚地区人乳头瘤病毒（HPV）致癌类型的最新进展
Cancers (Basel). 2021 May 30;13(11):2691. doi: 10.3390/cancers13112691.
10
Health workers' perspectives on barriers and facilitators to implementing a new national cervical cancer screening program in Ethiopia.卫生工作者对在埃塞俄比亚实施新的国家宫颈癌筛查计划的障碍和促进因素的看法。
BMC Womens Health. 2021 May 3;21(1):185. doi: 10.1186/s12905-021-01331-3.